MARKET

SEPN

SEPN

Septerna, Inc.
NASDAQ
37.77
-0.36
-0.94%
After Hours: 37.77 0 0.00% 19:30 09/25 EDT
OPEN
38.34
PREV CLOSE
38.13
HIGH
38.34
LOW
37.35
VOLUME
344.30K
TURNOVER
--
52 WEEK HIGH
51.10
52 WEEK LOW
15.41
MARKET CAP
1.76B
P/E (TTM)
-69.4174
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SEPN last week (0914-0918)?
Weekly Report · 6d ago
Weekly Report: what happened at SEPN last week (0907-0911)?
Weekly Report · 09/14 09:42
Wells Fargo Sticks to Their Buy Rating for Septerna, Inc. (SEPN)
TipRanks · 09/09 18:05
3 Small-Cap Stocks to Buy with 35%+ Upside, According to Analysts
TipRanks · 09/07 14:24
Weekly Report: what happened at SEPN last week (0831-0904)?
Weekly Report · 09/07 09:39
Weekly Report: what happened at SEPN last week (0824-0828)?
Weekly Report · 08/31 09:42
Septerna: GPCR Programs May Be Experimental, But I'm Holding For The Long Term
Seeking Alpha · 08/28 22:00
Septerna names Rajiv Patni as CMO
Seeking Alpha · 08/25 13:00
More
About SEPN
Septerna, Inc. is a clinical-stage biotechnology company. The Company is developing G protein-coupled receptor (GPCR) oral small-molecule drug discovery powered by its proprietary Native Complex Platform. It is advancing programs in endocrinology, immunology and inflammation, metabolic diseases and additional therapeutic areas, both independently and with partners. The Company's Native Complex Platform is designed to enable it to target certain GPCRs for the first time, uncover novel binding pockets for validated receptors, and pursue a wide spectrum of pharmacologies, including agonists, antagonists, and allosteric modulators, to achieve desired therapeutic effects. It is advancing a deep portfolio of oral small molecule GPCR-targeted programs with novel mechanistic approaches to treat diseases across multiple therapeutic areas for patients with significant unmet needs. It is focused on therapeutic areas, such as neurology, women’s health, cardiovascular, and respiratory disease.

Webull offers Septerna, Inc. stock information, including NASDAQ: SEPN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SEPN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SEPN stock methods without spending real money on the virtual paper trading platform.